Gastrointestinal Neoplasms

• 

  Subject Areas on Research

  • 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies. 
  • A Novel Approach: Local Resection for Ampullary GIST-Case Report and Review of Literature. 
  • A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis. 
  • A multiphase immunotherapy regimen for human melanoma: clinical and laboratory results. 
  • A novel conditionally replicating "armed" adenovirus selectively targeting gastrointestinal tumors with aberrant wnt signaling. 
  • A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity. 
  • A randomized pilot trial of a videoconference couples communication intervention for advanced GI cancer. 
  • A surgical oncology perspective on AIDS. 
  • Abdominal leiomyosarcoma: aggressive management. 
  • Acoustic radiation force impulse (ARFI) imaging of the gastrointestinal tract. 
  • Advanced imaging and technology in gastrointestinal neoplasia: summary of the AGA-NCI Symposium October 4-5, 2004. 
  • Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. 
  • Ambivalence over emotional expression in patients with gastrointestinal cancer and their caregivers: associations with patient pain and quality of life. 
  • American College of Surgeons Oncology Group and the community surgeon. 
  • Antioxidants and prevention of gastrointestinal cancers. 
  • Cancer and leukemia group B gastrointestinal cancer committee. 
  • Carcinoid tumors of the gastrointestinal tract. A review and the Duke University institutional overview. 
  • Cellular and biological therapies of gastrointestinal tumors: overview of clinical trials. 
  • Chemoradiotherapy in gastrointestinal malignancies. 
  • Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience. 
  • Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib. 
  • Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials. 
  • Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. 
  • Competing Mortality in Patients With Neuroendocrine Tumors. 
  • Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure. 
  • Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials. 
  • Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. 
  • Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. 
  • Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers. 
  • Diagnosis of gastrointestinal T-cell lymphomas in routinely processed tissues. 
  • Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. 
  • Diffuse neonatal hemangiomatosis: imaging findings in two patients. 
  • Disclosure between patients with gastrointestinal cancer and their spouses. 
  • Distinct Sleep Disturbance Profiles in Patients With Gastrointestinal Cancers Receiving Chemotherapy. 
  • Distinct profiles of multiple co-occurring symptoms in patients with gastrointestinal cancers receiving chemotherapy. 
  • Early outcomes of empiric embolization of tumor-related gastrointestinal hemorrhage in patients with advanced malignancy. 
  • Electronic patient-reported data capture as a foundation of rapid learning cancer care. 
  • Endoscopic ultrasound. State of the art. 
  • Epigenetic mechanisms underlying diet-sourced compounds in the prevention and treatment of gastrointestinal cancer. 
  • Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers. 
  • Fine-needle aspiration of gastrointestinal stromal tumors. 
  • Foregut carcinoids: a clinical and biochemical analysis. 
  • Gamma Knife radiosurgery for brain metastases from gastrointestinal primary. 
  • Gastrointestinal carcinoids: characterization by site of origin and hormone production. 
  • Gastrointestinal involvement and multiple lymphomatous polyposis in mantle-zone lymphoma. 
  • Gefitinib (Iressa, ZD1839) and tyrosine kinase inhibitors: the wave of the future in cancer therapy. 
  • Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. 
  • Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor). 
  • Gut organoids: mini-tissues in culture to study intestinal physiology and disease. 
  • Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. 
  • Image of the month. 
  • Intensity-modulated radiation therapy for gastrointestinal tumors. 
  • Intraoperative interstitial microwave-induced hyperthermia and brachytherapy. 
  • Intraoperative radiotherapy for gastrointestinal malignancies: contemporary outcomes with multimodality therapy. 
  • Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial. 
  • Lymphatic mapping and sentinel node analysis: current concepts and applications. 
  • Lymphomas of the gastro-intestinal tract - pathophysiology, pathology, and differential diagnosis. 
  • Malignant melanoma metastatic to the gastrointestinal tract. 
  • Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors. 
  • Mitomycin C and menadione for the treatment of advanced gastrointestinal cancers: a phase II trial. 
  • Mixed Adenoneuroendocrine Carcinoma, Amphicrine Type, of the Small Bowel. 
  • Mortality patterns of rock and slag mineral wool production workers: an epidemiological and environmental study. 
  • Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome. 
  • Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303. 
  • Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. 
  • Neuroendocrine neoplasms of the GI tract: the role of cytotoxic chemotherapy. 
  • Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy. 
  • New presentation of alpha heavy chain disease: North American polypoid gastrointestinal lymphoma. Clinical and cellular studies. 
  • On enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. 
  • Overcoming Resistance to Targeted Therapies in Gastrointestinal Cancers: Progress to Date and Progress to Come. 
  • Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome. 
  • Pancreatic cancer: future outlook, promising trials, newer systemic agents, and strategies from the Gastrointestinal Intergroup Pancreatic Cancer Task Force. 
  • Partner-assisted emotional disclosure for patients with GI cancer: 8-week follow-up and processes associated with change. 
  • Partner-assisted emotional disclosure for patients with gastrointestinal cancer: results from a randomized controlled trial. 
  • Percutaneous fine-needle aspiration of gastrointestinal wall lesions with image guidance. 
  • Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas. 
  • Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma. 
  • Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis. 
  • Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer. 
  • Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601. 
  • Primary gastrointestinal lymphoma. 
  • Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases. 
  • Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee. 
  • Radiologic imaging of AIDS. 
  • Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. 
  • Reconstruction with vascularized composite tissue in patients with excessive injury following surgery and irradiation. 
  • Reflectance spectroscopy. 
  • Reflections on Anthony Zietman From Gastrointestinal Cancer and Physics Editors. 
  • Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract. 
  • Risk Factors for Hospitalizations Among Older Adults with Gastrointestinal Cancers. 
  • Risk of Pelvic Fracture With Radiation Therapy in Older Patients. 
  • Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study. 
  • Sexual concerns in cancer patients: a comparison of GI and breast cancer patients. 
  • Should abdominal cluster transplantation be abandoned? 
  • Signet ring adenocarcinoma metastatic to the bronchus and mimicking goblet cell hyperplasia. A case report. 
  • Small-bowel malabsorption and gastrointestinal malignancy. 
  • Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors. 
  • Surgical options for advanced/metastatic gastrointestinal stromal tumors. 
  • Surgical therapy of localized abdominal non-Hodgkin's lymphomas. 
  • Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress? 
  • Synchronous occurrence of gastrointestinal stromal tumour and ovarian neoplasm in a patient presenting with acute cholecystitis. 
  • Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type? 
  • Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. 
  • Technology Assessment Status Evaluation: tissue sampling during endosonography. February 1997. ASGE. American Society for Gastrointestinal Endoscopy. 
  • The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors. 
  • The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors. 
  • The role of surgery for patients with metastatic melanoma. 
  • The social context of gastrointestinal cancer pain: a preliminary study examining the relation of patient pain catastrophizing to patient perceptions of social support and caregiver stress and negative responses. 
  • The surgical management of metastatic melanoma. 
  • Themes Addressed by Couples With Advanced Cancer During a Communication Skills Training Intervention. 
  • Tomorrow's cancer treatments today: the first 50 years of the Cancer and Leukemia Group B. 
  • Top Ten Tips Palliative Care Clinicians Should Know About Interventional Symptom Management Options When Caring for Patients with Gastrointestinal Malignancies. 
  • Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL. 
  • Use of Everolimus After Multivisceral Transplantation: A Report of Two Cases. 
  • Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. 
  • Variations of very low-density lipoprotein receptor subtype expression in gastrointestinal adenocarcinoma cells with various differentiations. 
  • What's new in gastrointestinal and hepatobiliary surgery. 
  • Widespread organ tolerance to Xist loss and X reactivation except under chronic stress in the gut. 
  • beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. 
  • mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. 
• 

  Keywords of People

  • Dement, John McCray, Professor Emeritus in Family Medicine and Community Health, Family Medicine & Community Health,Occupational & Environmental Medicine
  • Jowell, Paul Simon, Professor of Medicine, Medicine, Gastroenterology
  • Kim, Charles Yoon, Professor of Radiology, Radiology, Interventional Radiology
  • Uronis, Hope Elizabeth, Associate Professor of Medicine, Medicine, Medical Oncology
  • Zafar, Syed Yousuf, Adjunct Professor in the Department of Medicine, Duke Science & Society